Loading clinical trials...
Loading clinical trials...
This study will be conducted to evaluate the efficacy and safety of a single dose of nexiguran ziclumeran (NTLA-2001) compared to placebo in participants with ATTRv-PN.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Intellia Therapeutics
Collaborators
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT06821230 · Mindfulness, Caregivers, and more
NCT00271622 · Neurologic Disorders, Autism, and more
NCT04838301 · Alzheimer Dementia, Late Onset Alzheimer Disease, and more
NCT06084026 · Neuromuscular Diseases
Hospital Británico de Buenos Aires
Buenos Aires
Hospital Italiano de Buenos Aires (HIBA)
Buenos Aires
Hospital El Cruce
San Juan Bautista
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions